Standout Papers

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target 2017 2026 2020 2023 739
  1. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target (2017)
    Robert T. Manguso, Hans W. Pope et al. Nature

Immediate Impact

3 by Nobel laureates 25 from Science/Nature 97 standout
Sub-graph 1 of 18

Citing Papers

SOX17 enables immune evasion of early colorectal adenomas and cancers
2024 StandoutNature
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
6 intermediate papers

Works of Brian C. Miller being referenced

PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
2019
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
2017 StandoutNature

Author Peers

Author Last Decade Papers Cites
Brian C. Miller 920 659 1086 1057 22 2.4k
Kevin Shenderov 2402 418 1354 1046 16 4.1k
Youtong Wu 1944 395 1954 1208 21 3.7k
Laura M. Bartle 539 514 881 840 27 2.1k
Paul R. Sleath 1351 567 1169 1380 22 3.4k
Lianfa Shi 1142 578 2262 789 18 3.5k
Oliver Florey 1187 268 1273 1427 46 3.6k
Kylie A. Browne 1330 421 1280 416 37 2.9k
Monique Flacher 866 268 699 556 33 2.3k
Oliver Schoor 1156 512 933 432 33 1.9k
Dorothee Schmid 1093 190 575 1341 12 2.3k

All Works

Loading papers...

Rankless by CCL
2026